| Name | Tamgiblimab |
|---|
| Description | Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |